Evidence map›Paper›PMID 38421682›Full record

ArticleBlood cancer discovery2024

Spatial Mapping of Hematopoietic Clones in Human Bone Marrow.

Andrew L Young, Hannah C Davis, Maggie J Cox, Tyler M Parsons, Samantha C Burkart, Diane E Bender, Lulu Sun, Stephen T Oh, Grant A Challen

Open access · hybridAbstract read
In one paragraph

Article in Blood cancer discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. Hematopoietic Clonal Evolution Goes Spatial.Blood cancer discovery · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andrew L YoungDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0001-7698-3267
Hannah C DavisDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0009-0003-3005-6072
Maggie J CoxDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0009-0003-9783-6698
Tyler M ParsonsDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0003-0277-1557
Samantha C BurkartDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0009-0008-8375-8699
Diane E BenderThe Bursky Center for Human Immunology and Immunotherapy Programs Immunomonitoring Laboratory, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0002-8311-4390
Lulu SunDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0001-7543-1532
Stephen T OhDivision of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0002-8564-5400
Grant A ChallenDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0003-4669-8814
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
Specimen Acquistition and Expression ProfilingP01CA101937 · NCI · WASHINGTON UNIVERSITY · PI LINK, DANIEL C · 2003 to 2023
$58.8M
PRE-AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGYT32HL007088 · NHLBI · WASHINGTON UNIVERSITY · PI Grant Anthony Challen, Stephen Oh · 1985 to 2026
$14.1M
DYSREGULATED NFKB PATHWAY SIGNALING IN MYELOPROLIFERATIVE NEOPLASMSR01HL134952 · NHLBI · WASHINGTON UNIVERSITY · PI Stephen Oh · 2018 to 2026
$3.9M
Inflammatory Stress Promotes Clonal Expansion of DNMT3A-mutant HSCsR01DK124883 · NIDDK · WASHINGTON UNIVERSITY · PI Grant Anthony Challen · 2020 to 2026
$2.5M
JAK/STAT signaling in the pathogenesis of DNMT3A mutant T-ALLR01CA236819 · NCI · WASHINGTON UNIVERSITY · PI CHALLEN, GRANT ANTHONY · 2020 to 2024
$1.8M
Functions of JARID2 in Normal and Neoplastic HematopoiesisR01HL147978 · NHLBI · WASHINGTON UNIVERSITY · PI CHALLEN, GRANT ANTHONY · 2019 to 2022
$1.6M
Single Cell Spatial Characterization of the Human Bone Marrow MicroenvironmentR21HL150636 · NHLBI · WASHINGTON UNIVERSITY · PI LINK, DANIEL C, OH, STEPHEN TRACY · 2020 to 2021
$433k
NCI NIH HHS P01 CA101937NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA236819NHLBI NIH HHS R01 HL134952NHLBI NIH HHS R01 HL147978NHLBI NIH HHS R21 HL150636NHLBI NIH HHS T32 HL007088NIDDK NIH HHS R01 DK124883
6 · The paper itself

Abstract

Clonal hematopoiesis (CH) is the expansion of somatically mutated cells in the hematopoietic compartment of individuals without hematopoietic dysfunction. Large CH clones (i.e., >2% variant allele fraction) predispose to hematologic malignancy, but CH is detected at lower levels in nearly all middle-aged individuals. Prior work has extensively characterized CH in peripheral blood, but the spatial distribution of hematopoietic clones in human bone marrow is largely undescribed. To understand CH at this level, we developed a method for spatially aware somatic mutation profiling and characterized the bone marrow of a patient with polycythemia vera. We identified the complex clonal distribution of somatic mutations in the hematopoietic compartment, the restriction of somatic mutations to specific subpopulations of hematopoietic cells, and spatial constraints of these clones in the bone marrow. This proof of principle paves the way to answering fundamental questions regarding CH spatial organization and factors driving CH expansion and malignant transformation in the bone marrow. SIGNIFICANCE: CH occurs commonly in humans and can predispose to hematologic malignancy. Although well characterized in blood, it is poorly understood how clones are spatially distributed in the bone marrow. To answer this, we developed methods for spatially aware somatic mutation profiling to describe clonal heterogeneity in human bone marrow. See related commentary by Austin and Aifantis, p. 139.

Indexed as

Bone MarrowClonal HematopoiesisMutationClone CellsHematopoietic Stem CellsHumansPolycythemia Vera

Identifiers

PMID38421682
PMCPMC11062237
OpenAlexW4392297499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.